Luye Pharma Group (HK:2186) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Luye Pharma Group has announced plans to issue convertible bonds worth $150 million, with a 5.85% interest rate due in 2025. The proceeds will be used for refinancing existing debt, research and development, and general corporate purposes. The bonds, which can be converted into shares, are part of a strategic move to strengthen the company’s financial position.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue